Fingerprint
Dive into the research topics of 'TBCRC026: Phase II trial correlating standardized uptake value with pathologic complete response to pertuzumab and trastuzumab in breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically